Evidence map›Paper›PMID 39610800›Full record

ArticleAdvances in radiation oncology2024

Rotationally Intensified Proton Lattice: A Novel Lattice Technique Using Spot-Scanning Proton Arc Therapy.

Joseph S Lee, Derek A Mumaw, Peilin Liu, Bailey A Loving, Ebin Sebastian, Xiaoda Cong, Mark S Stefani, Brian F Loughery, Xiaoqiang Li, Rohan Deraniyagala and 3 more

Abstract read
In one paragraph

Article in Advances in radiation oncology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Joseph S LeeDepartment of Radiation Oncology, Corewell Health William Beaumont University Hospital, Royal Oak, Michigan.
Derek A MumawDepartment of Radiation Oncology, Corewell Health William Beaumont University Hospital, Royal Oak, Michigan.
Peilin LiuDepartment of Radiation Oncology, Corewell Health William Beaumont University Hospital, Royal Oak, Michigan.
Bailey A LovingDepartment of Radiation Oncology, Corewell Health William Beaumont University Hospital, Royal Oak, Michigan.
Ebin SebastianDepartment of Radiation Oncology, Corewell Health William Beaumont University Hospital, Royal Oak, Michigan.
Xiaoda CongDepartment of Radiation Oncology, Corewell Health William Beaumont University Hospital, Royal Oak, Michigan.
Mark S StefaniDepartment of Radiation Oncology, Corewell Health William Beaumont University Hospital, Royal Oak, Michigan.
Brian F LougheryDepartment of Radiation Oncology, Corewell Health Dearborn Hospital, Dearborn, Michigan.
Xiaoqiang LiDepartment of Radiation Oncology, Corewell Health William Beaumont University Hospital, Royal Oak, Michigan.
Rohan DeraniyagalaDepartment of Radiation Oncology, Corewell Health William Beaumont University Hospital, Royal Oak, Michigan.
Muayad F AlmahariqDepartment of Radiation Oncology, Corewell Health Dearborn Hospital, Dearborn, Michigan.
Xuanfeng DingDepartment of Radiation Oncology, Corewell Health William Beaumont University Hospital, Royal Oak, Michigan.
Thomas J QuinnDepartment of Radiation Oncology, Corewell Health William Beaumont University Hospital, Royal Oak, Michigan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: The aim of this study was to explore the feasibility and dosimetric advantage of using spot-scanning proton arc (SPArc) for lattice radiation therapy in comparison with volumetric-modulated arc therapy (VMAT) and intensity modulated proton therapy (IMPT) lattice techniques. Methods: Lattice plans were retrospectively generated for 14 large tumors across the abdomen, pelvis, lung, and head-and-neck sites using VMAT, IMPT, and SPArc techniques. Lattice geometries comprised vertices 1.5 cm in diameter that were arrayed in a body-centered cubic lattice with a 6-cm lattice constant. The prescription dose was 20 Gy (relative biological effectiveness [RBE]) in 5 fractions to the periphery of the tumor, with a simultaneous integrated boost of 66.7 Gy (RBE) as a minimum dose to the vertices. Organ-at-risk constraints per American Association of Physicists in Medicine Task Group 101were prioritized. Dose-volume histograms were extracted and used to identify maximum, minimum, and mean doses; equivalent uniform dose; D95%, D50%, D10%, D5%; V19Gy; peak-to-valley dose ratio (PVDR); and gradient index (GI). The treatment delivery time of IMPT and SPArc were simulated based on the published proton delivery sequence model. Results: Median tumor volume was 577 cc with a median of 4.5 high-dose vertices per plan. Low-dose coverage was maintained in all plans (median V19Gy: SPArc 96%, IMPT 96%, VMAT 92%). SPArc generated significantly greater dose gradients as measured by PVDR (SPArc 4.0, IMPT 3.6, VMAT 3.2; SPArc-IMPT Conclusions: SPArc therapy was able to achieve high-quality lattice plans for various sites with superior gradient metrics (PVDR and GI) when compared with VMAT and IMPT. Clinical implementation is warranted.

Identifiers

PMID39610800
PMCPMC11603120

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.